The rapid assimilation of artificial intelligence into the clinical environment has precipitated an unprecedented metacognitive crisis. For decades, the medical profession relied on a structured hierarchy of expertise where competence was calibrated through rigorous training, peer review, and the incremental acquisition of experience.

The Exit Factor: Why M&A is on the rise in HealthTech. By mid-2025 healthcare deal value had soared 87% to €31.8 billion, even as deal count slid 8% according to Nelson Advisors. In the UK, 168 healthtech exits landed by the end of 2024 against just 61 failures. M&A is no longer a side strategy; it’s the headline act and primary way buyers access innovation, capability, and competitive edge.